Celgene logo Celgene Logo
Search

  • Canada
    • Australia
      • English
    • Austria
      • Deutsch
    • Belgium
      • Français
      • Nederlands
    • Brazil
      • Português
    • Canada
      • English
      • Français
    • Czech Republic
      • Čeština
    • Denmark
      • Dansk
    • Europe
      • English
    • Finland
      • Suomi
    • France
      • Français
    • Germany
      • Deutsch
    • Ireland
      • English
    • Italy
      • Italiano
    • Japan
      • 日本語
    • Luxembourg
      • Français
      • Nederlands
    • Mexico
      • Español
    • Netherlands
      • Nederlands
    • Norway
      • Norsk
    • Poland
      • Polski
    • Portugal
      • Português
    • Russia
      • Русский язык
    • South Korea
      • 한국어
    • Spain
      • Español
    • Sweden
      • Svenska
    • Switzerland
      • Deutsch
      • Français
    • Turkey
      • Türk
    • United Kingdom
      • English
    • United States
      • English
  • English
    • Français
  • About
    • Compliance
    • History
    • Global Office Locations
  • Product Information
    • Anti-counterfeiting
  • Research & Development
    • Product Pipeline
    • Medical Innovation
      • IMiDs
      • Anti-inflammatory Compounds
      • nab® Technology
    • R&D Locations
      • CITRE
      • Drug Discovery & Alliance Development
    • Clinical Trials
    • Celgene Medical Affairs
  • Responsibility
    • Patients & Communities
    • Commitment to Safety
      • Patient Safety
    • Global Health
  • Newsroom
    • Press Releases
  • Patients
    • Online Patient Resources
  • Investors
  • Careers
  • Contact Us
  • Home Page
  • Research & Development

Research & Development

Developing innovative therapies that address the source of disease, not just the symptoms

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Clinical Trials

Celgene sponsors dozens of clinical trials that are actively recruiting patients in a wide variety of disease areas.

Medical Innovation

Innovation is at the core of our therapies, turning knowledge about disease mechanisms at the genetic and cellular level into treatments that manage, prevent and ultimately cure illness.

R&D Locations

Celgene research facilities around the world enable scientists and physicians to find solutions for managing complex human disease. 

Related Links

Download the Material Request Form

Learn about our approved therapies

Product Pipeline

Celgene invests significant resources into creating disease-altering therapies for cancers and serious inflammatory conditions. Hundreds of clinical studies around the world use our innovative treatments.

Font Size Smaller Font Size Larger Font Size
  • About
    • Compliance
    • History
    • Global Office Locations
  • Product Information
    • Anti-counterfeiting
  • Research & Development
    • Product Pipeline
    • Medical Innovation
      • IMiDs
      • Anti-inflammatory Compounds
      • nab® Technology
    • R&D Locations
      • CITRE
      • Drug Discovery
    • Clinical Trials
    • Celgene Medical Affairs
  • Responsibility
    • Patients & Communities
    • Commitment to Safety
      • Patient Safety
    • Global Health
  • Newsroom
    • Press Releases
  • Patients
    • Online Patient Resources
  • Investors
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map

Global Office Locations

world map

HAVE A QUESTION OR CONCERN?
CONTACT US

  • About
  • Product Information
  • Research & Development
  • Responsibility
  • Newsroom
  • Patients
  • Investors
  • Careers
  • Pipeline
  • Privacy Policy
  • Legal Notice
  • Site Map



This Site Is Intended For Canadian Audiences.

  • Copyright © 2021 Celgene Corporation
    A Bristol Myers Squibb Company
  • Accessibility
    Policy
  • Multi-Year
    Accessibility
  • Legal
    Notice
  • Privacy
    Policy
  • Newsroom
    • Press Releases
X

You are now leaving Celgene.ca. Celgene is not responsible for, and does not in any way oversee, manage, operate, provide or endorse, any third party website or any products, services or content on such third party website. Celgene’s Terms of Use and Privacy Policy are not applicable to any third party website and so Celgene recommends that you review the terms of use, privacy and/or data security policies of any such third party websites.

Continue

To view

Cancel

To return to www.Celgene.ca

These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed under the Global Network).

Continue

To view

Cancel

To return to www.Celgene.com

Celgene is now part of Bristol-Myers Squibb


Select CONTINUE for information about Celgene.

Select BMS to learn more about Bristol-Myers Squibb.



CONTINUE BMS